Isabel Cunningham MD
Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Adjunct Associate Research Scientist, Hem Onc, Columbia University
Join to View Full Profile
310 West 72nd StNew York, NY 10023
Phone+1 212-721-9221
Dr. Cunningham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1982 - 1983
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1979 - 1982
Yale School of MedicineClass of 1979
Certifications & Licensure
NY State Medical License 1981 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Relentless for the Cure Award Leukemia & Lymphoma Society, NYC chapter, 2006
- Memorial Sloan-Kettering Hematology Fellows' Teaching Award 1989
Publications & Presentations
PubMed
- 1 citationsA single organ microenvironment and the common features of tumors of leukemia, lymphoma, and myeloma cells growing there. A literature reviewIsabel Cunningham, Sergio Sánchez Sosa, Diane Hamele-Bena
European Journal of Haematology. 2021-11-15 - 6 citationsPost-transplant leukemia relapse in organs: biology. and behavior in 585 reports.Isabel Cunningham
Critical Reviews in Oncology/hematology. 2021-01-01 - 8 citationsExtramedullary leukemia behaving as solid cancer: clinical, histologic, and genetic clues to chemoresistance in organ sites.Isabel Cunningham, Diane Hamele-Bena, Yan Guo, Takayuki Shiomi, Audrey C. Papp
American Journal of Hematology. 2019-11-01
Abstracts/Posters
- Dasatinib as targeted therapy for post-transplant extramedullary relapseCunningham, I, and Mensah-Glanowska, P., European Bone Marrow Transplant meeting, Florence, Italy, 3/31/2025
- Dasatinib targets an upregulated src family kinase gene in extramedullary leukemia improving prognosis in these patientsCunningham, I., Yang, J., Newton, H.B., Fisher, R.A., AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, Mass, 10/2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
